Souhaitez-vous accéder aux communiqués récents ?

Austin, United States, Aug. 03, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the Single-Cell Multiomics Market Size was valued at USD 2.99 Billion in 2025 and is projected to reach USD 18.20...

Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears...

Austin, United States, July 23, 2026 (GLOBE NEWSWIRE) -- The Human Microbiome Market Size was valued at USD 1.39 Billion in 2025 and is projected to reach USD 7.66 Billion by 2035, growing at a CAGR...

Dublin, July 22, 2026 (GLOBE NEWSWIRE) -- The "Genomic Collaboration and Licensing Deals 2018-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...

Dublin, July 20, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering. The global cell...

Austin, United States, July 15, 2026 (GLOBE NEWSWIRE) -- The Autoimmune Disease Therapeutics Market size was valued at USD 80.54 Billion in 2025 and is projected to reach USD 137.85 Billion by 2035,...

Dublin, July 14, 2026 (GLOBE NEWSWIRE) -- The "Transgenic Animal Model Market - A Global and Regional Analysis: Focus on Technology, Animal Type, Application, End User, and Regional Analysis -...

Austin, United States, July 13, 2026 (GLOBE NEWSWIRE) -- The Single-Cell Sequencing Market Size was valued at USD 2.43 Billion in 2025 and is projected to reach USD 9.83 Billion by 2035, expanding...

Dublin, July 10, 2026 (GLOBE NEWSWIRE) -- The "Generative AI in Drug Discovery Market Report 2026" has been added to ResearchAndMarkets.com's offering. The generative artificial intelligence...

Chemomab and Scipher announced a merger agreement to advance nebokitug into a Phase 2 precision medicine trial for the treatment of rheumatoid arthritis.